COVID19 Vaccine: Statutory Nod For Zydus Cadila Vax For 12-18 Age-Group Soon, Centre To HC

The Centre said the vaccination is its top most priority and all efforts are being made to achieve " an objective of 100 percent vaccination in the shortest time possible keeping the available resources in mind and availability of vaccine doses into consideration".

COVID19 Vaccine: Statutory Nod For Zydus Cadila Vax For 12-18 Age-Group Soon, Centre To HC

News Summary

In June last week, the Centre had informed the Supreme Court that Zydus Cadila, has concluded its clinical trials for the 12 to 18 age group, and the vaccine may be available in near future, subject to the statutory permissions.

New Delhi: The Centre has informed the Delhi High Court that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for the age group of 12 to 18.

The affidavit filed by under secretary, Department of Health and Family Welfare, said: "It is submitted that Zydus Cadila, which is developing DNA vaccines has concluded its clinical trial for between the age group of 12 to 18 and subject to the statutory permissions, the same may be available in near future for children of the age group of 12 to 18 years of age".